Emerging experimental drugs in clinical trials for migraine: observations and key talking points.
- DOI
- 10.1080/13543784.2023.2254691
- Published
- 2023 Jul-Dec
- Container
- Expert opinion on investigational drugs
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/13543784.2023.2254691,
title = {Emerging experimental drugs in clinical trials for migraine: observations and key talking points.},
author = {Wells-Gatnik WD and Wences Chirino TY and Onan FN and Onan D and Martelletti P},
year = {2023},
journal = {Expert opinion on investigational drugs},
doi = {10.1080/13543784.2023.2254691},
url = {https://doi.org/10.1080/13543784.2023.2254691}
}RIS
TY - JOUR TI - Emerging experimental drugs in clinical trials for migraine: observations and key talking points. AU - Wells-Gatnik WD AU - Wences Chirino TY AU - Onan FN AU - Onan D AU - Martelletti P PY - 2023 JO - Expert opinion on investigational drugs DO - 10.1080/13543784.2023.2254691 UR - https://doi.org/10.1080/13543784.2023.2254691 ER -
APA
WD, W., TY, W. C., FN, O., D, O., & P, M. (2023). Emerging experimental drugs in clinical trials for migraine: observations and key talking points.. Expert opinion on investigational drugs. https://doi.org/10.1080/13543784.2023.2254691
Source records
- pubmed · retrieved 2026-09-25T22:48:31.300Z
- europe-pmc · retrieved 2026-09-25T22:48:31.301Z